Navigation Links
MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone

Seven year follow up of pivotal trial confirms that more patients are alive today due to MabThera

BASEL, Switzerland, June 4, 2007-A follow-up analysis tracking the outcome of patients with aggressive non-Hodgkin's lymphoma (NHL) who were treated with the innovative cancer therapy MabThera (rituximab) over seven years ago has revealed exciting results (1).

This analysis of the original pivotal phase III study has shown that over half (53%) of the patients treated with MabThera were still alive after seven years compared with just over a third (36%) of patients who had received chemotherapy alone. This means that for every 100 patients with aggressive NHL, 17 more patients would be alive at seven years due to MabThera.

The analysis also demonstrated that more MabThera treated patients were in remission at seven years compared to chemotherapy alone, 52% vs. 29%. As remissions of greater than 5 years are generally considered to be a cure, this study clearly demonstrates that the addition of MabThera to treatment cures more patients with aggressive lymphoma than chemotherapy alone. These benefits are irrespective of age and are seen even in patients with high risk characteristics.

This study outcome, presented at the American Society of Clinical Oncology meeting in Chicago, highlights the impressive impact that MabThera is having on aggressive NHL, a disease in which it has already saved thousands of lives.

"This long-term analysis clearly demonstrates the benefits that MabThera, in combination with chemotherapy, provides to patients with aggressive lymphoma," commented Prof. Bertrand Coiffier, from the Centre Hospitalier Lyon-Sud, a primary investigator of the study. "Furthermore, the results confirm that the addition of MabThera to treatment is critical even for older patients as the benefits were seen in all age groups."

"MabThera continues to prolong and rebuild life for patie
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
2. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients

Post Your Comments:
(Date:11/6/2009)... 6 Trius Therapeutics, Inc. announ...nt on Form S-1 with the U.S. Securities and Exchan... public offering of shares of its common stock. Al...ering will be offered by the Company. ,, Credit...k-running manager, Piper Jaffray & Co. is acti...
(Date:11/6/2009)... Caraco Pharmaceutical L...ketorolac tromethamine ophthalmic solution, 0.5% f...g Administration (FDA) for Sun Pharma,s Abbreviate...174; ophthalmic solution on the first day followin... therapeutically equivalent to Acular® Ophtha...
(Date:11/6/2009)... 6 NuVasive, Inc. (Nasda...veloping products for minimally disruptive surgica...pointment of Michael J. Lambert as Executive Vice ...ovember 9, 2009. The Company also announced sever..."Michael will be an excellent complement to the Nu...
Breaking Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Switching on the power of stem cells 9639 1Switching on the power of stem cells 9639 2Princeton team learns why some drugs pack such a punch 9635 1Princeton team learns why some drugs pack such a punch 9635 2Princeton team learns why some drugs pack such a punch 9635 3CSC Announces Agreement to Provide Billing Service to Colorado West Dermatology 54964 1CSC Announces Agreement to Provide Billing Service to Colorado West Dermatology 54964 2
...vember 19 NeuroDiscovery Ltd (ASX:,NDL), a specia...ment Company,and Sosei Group Corporation ("Sosei";... biopharmaceutical company, today announce that Ne...nical efficacy data for NSL-043/SD118.,This invest...hic pain and has,successfully completed Phase I cl...
...a., Nov. 18 Arlington Medical Resources (AMR), a,...armaceutical and diagnostic,imaging industries, fi...n was,sold in the U.S. during the third quarter of... immune globulin (IVIG) and was launched in the fi...m the blood plasma of thousands,of donors and is u...
Other Medicine Technology:Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2
(Date:11/9/2009)...ity study involving 2,453 women ages 18 to 68 foun...or with a partner contributed to higher ratings of...ricants have long been recommended to women to imp...ce the risk of vaginal tearing, yet strikingly lit...lubricants or associated vaginal symptoms. , Th...
(Date:11/8/2009)... 8 Jon O,Brien, preside...tatement about the passage of HR 3962: ,, "Beh...ters a lot about core values. We in the prochoice ...to overcome the struggles ordinary Americans have ...annot afford basic healthcare or have to choose be...
(Date:11/8/2009)...v. 8 The American Publi...n and wellness provisions in the health reform bil...age of this bill, the House takes important steps ...surance reforms and moving our health system from ...focuses on keeping people healthy," said Georges C...
(Date:11/8/2009)...ut position promotes self-assurance, research find... Your mother may have been right when she told you...od posture could make you feel more confident abou...t sitting up straight gives a good impression to o...y and a psychology professor at Ohio State Univers...
(Date:11/8/2009)...take you out of the game later, doctors say , ...juries are the talk of the NFL this season, sideli...ning back Willie Parker. , Officials at the Ame...cademy of Podiatric Sports Medicine are warning at...all sports like football and lacrosse. , "Many ...
Breaking Medicine News(10 mins):Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 2Health News:Indiana U. at APHA: Studies about why men and women use lubricants during sex 3Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:APHA Applauds Prevention and Wellness Provisions in House Health Reform Bill 2Health News:Good Posture May Inspire Confidence 2Health News:Rx for Fall Foot Injuries 2
...March 4, 2009 AMERIGROUP Corporation (NYSE: A...he Barclays Capital Global Healthcare Conference o...oadcast of the Company,s presentation, which begin... be available for 30 days, and can be accessed at ...
... 4 The American Association of Homes and Services... Committee on Aging and its chair, Sen. Herb Kohl ...m services and support must be a part of health ca... are high. Insurance coverage is nearly non-existe...
...Support of Postal Bill on Capitol Hill , , ALEXAN...cNearney (D-Calif.) became the 76th Co-Sponsor of ...retiree health benefits obligation. The bill, ori...e U.S. House of Representatives. , , H.R. 22 woul...
... ASAP Systems today introduced its next generat...ftware applications for its Passport Inventory, As...modular and can be customized within minutes by us... mobile software applications for its Passport Inv...
...s you a "dirty rat," consider it a compliment. A n...l ( http://www.fasebj.org ) shows that cellular m...e very low oxygen environment of its subterranean ...serve a "living tumor" in cancer research; andperh...
...In the past year, the United States Agency for Int...gram assisted over one million people through eye ...refractive error correction, sight-restoring surge...r one million people in 23 countries. Together, th...
Other Medicine News:Health News:AAHSA Statement on Senate Special Committee on Aging Hearing, 'Health Reform in an Aging America' 2Health News:Congressman Jerry McNearney (D-Calif.) becomes 76th Co-Sponsor of H.R. 22 2Health News:ASAP Systems Passport Gets Cutting-Edge Mobile Inventory, Asset and Property Tracking Software 2Health News:ASAP Systems Passport Gets Cutting-Edge Mobile Inventory, Asset and Property Tracking Software 3Health News:A new soldier in the war on cancer: The blind mole rat 2Health News:USAID Blindness Program Assists One Million Children in 23 Countries 2Health News:USAID Blindness Program Assists One Million Children in 23 Countries 3
Monitect Multiple Drug Screen Cassette Test
...ystem is a patient insertable short-term sensor th...the DexCom STS Receiver., The DexCom STS Sens...a the DexCom STS Applicator by the user or clinici...y an adhesive to the skin. Once inserted the user ...
Vision Holter Analysis System
...n to Electronic Medical Records (EMRs). , Wit...nto physicans' offices, exciting innovations in di...urdick's Universal ECG can be interfaced with most...oking for tools to support the transition to a pap...
Medicine Products: